Preclinical Animal Models for Cancer Genomics

Cancer Genomics: From Bench to Personalized Medicine

Volumn , Issue , 2013, Pages 109-131

  Berman, Jason N ^a   Chiu, Priscilla P L ^b   Dellaire, Graham ^c  

^a DALHOUSIE UNIVERSITY   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Chicken; Dog; Mouse; Preclinical; Transgenic models; Xenograft; Zebrafish

Indexed keywords

EID: 84902406131     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-396967-5.00008-6     Document Type: Chapter

References (197)

1. Murphy J.B. Transplantability of tissues to the embryo of foreign species. Its bearing on questions of tissue specificity and tumor immunity. J Exp Med 1913, 17:482-493.
2. Greene H. The heterologous transplantation of mouse tumors induced in vitro. Cancer Res 1946, 6:396-402.
3. Quayle J. Ability of CEA blood levels to reflect tumour burden: a study in a human xenograft model. Br J Cancer 1982, 46:220-227.
4. Flanagan S. 'Nude', a new hairless gene with pleiotropic effects in the mouse. Genet Res 1966, 8:295-309.
5. Pantelouris E.M., Hair J. Thymus dysgenesis in nude (nu nu) mice. J Embryol Exp Morphol 1970, 24:615-623.
6. Povlsen C., Rygaard J. Heterotransplantation of human adenocarcinomas of the colon and rectum to the mouse mutant Nude. A study of nine consecutive transplantations. Acta Pathol Microbiol Scand A 1971, 79:159-169.
7. Giovanella B., Stehlin J., Williams L.J. Heterotransplantation of human malignant tumors in "nude" thymusless mice. II. Malignant tumors induced by injection of cell cultures derived from human solid tumors. J Natl Cancer Inst 1974, 52:921-930.
8. Clarke R., Dickson R. Animal models of tumor onset, growth, and metastasis. Encyclopedia of cancer 1997, Academic Press, New York. J. Bertino (Ed.).
9. Bosma G., Custer R. A severe combined immunodeficiency mutation in the mouse. Nature 1983, 301:527-530.
10. Theocharides A., Jin L., Cheng P., Prasolava TK, Malko AV, Ho JM, et al. Disruption of SIRPα signaling in macrophages eliminates human acute myeloid leukemia stem cells in xenografts. J Exp Med 2012, 209:1883-1899.
11. Lapidot T., Sirard C., Vormoor J., Murdoch B, Hoang T, Caceres-Cortes J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994, 367:645-648.
12. Cox C., Martin H., Kearns P., Virgo P., Evely R., Blair A. Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia. Blood 2007, 109:674-682.
13. Thiollier C., Lopez C., Gerby B., Ignacimouttou C, Poglio S, Duffourd Y, et al. Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models. J Exp Med 2012, 209:2017-2031.
14. Lock R.B., Liem N., Farnsworth M.L., Milross CG, Xue C, Tajbakhsh M, et al. The nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics at diagnosis and relapse. Blood 2002, 99:4100-4108.
15. Chiu P., Jiang H., Dick J.E. Leukemia-initiating cells in human T-lymphoblastic leukemia exhibit glucocorticoid resistance. Blood 2010, 116:5268-5279.
16. Singh S., Hawkins C., Clarke I., Squire JA, Bayani J, Hide T, et al. Identification of human brain tumour intiating cells. Nature 2004, 432:396-401.
17. O'Brien C., Pollett A., Gallinger S., Dick J. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007, 445:106-110.
18. Ricci-Vitiani L., Lombardi D., Pilozzi E., Biffoni M, Todaro M, Peschle C, et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445:111-115.
19. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003, 100:3983-3988.
20. Quintana E., Shackleton M., Sabel M.S., Fullen D.R., Johnson T.M., Morrison S.J. Efficient tumour formation by single human melanoma cells. Nature 2008, 456:593-599.
21. Brinster R.L., Chen H.Y., Messing A., van Dyke T., Levine A.J., Palmiter R.D. Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors. Cell 1984, 37:367-379.
22. Stewart T.A., Pattengale P.K., Leder P. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 1984, 38:627-637.
23. Karlsson E.K., Lindblad-Toh K. Leader of the pack: gene mapping in dogs and other model organisms. Nat Rev Genet 2008, 9:713-725.
24. Cimpean A.M., Ribatti D., Raica M. The chick embryo chorioallantoic membrane as a model to study tumor metastasis. Angiogenesis 2008, 11:311-319.
25. Stoletov K., Klemke R. Catch of the day: zebrafish as a human cancer model. Oncogene 2008, 27:4509-4520.
26. Potts M.B., Cameron S. Cell lineage and cell death: Caenorhabditis elegans and cancer research. Nat Rev Cancer 2011, 11:50-58.
27. Rudrapatna V.A., Cagan R.L., Das T.K. Drosophila cancer models. Dev Dyn 2012, 241:107-118.
28. Payne E., Look T. Zebrafish modelling of leukaemias. Br J Haematol 2009, 146:247-256.
29. Amatruda J.F., Shepard J.L., Stern H.M., Zon L.I. Zebrafish as a cancer model system. Cancer Cell 2002, 1:229-231.
30. Berghmans S., Jette C., Langenau D., Hsu K, Stewart R, Look T, et al. Making waves in cancer research: new models in the zebrafish. BioTechniques 2005, 39:227-237.
31. Langenau D.M., Keefe M.D., Storer N.Y., Guyon JR, Kutok JL, Le X, et al. Effects of RAS on the genesis of embryonal rhabdomyosarcoma. Genes Dev 2007, 21:1382-1395.
32. Gutierrez A., Grebliunaite R., Feng H., Kozakewich E, Zhu S, Guo F, et al. Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia. J Exp Med 2011, 208:1595-1603.
33. Parng C., Seng W.L., Semino C., McGrath P. Zebrafish: a preclinical model for drug screening. Assay Drug Dev Technol 2002, 1:41-48.
34. Amatruda J.F., Patton E.E. Genetic models of cancer in zebrafish. Int Rev Cell Mol Biol 2008, 271:1-34.
35. Spitsbergen J.M., Tsai H.W., Reddy A., Miller T, Arbogast D, Hendricks JD, et al. Neoplasia in zebrafish (Danio rerio) treated with 7,12-dimethylbenz[a]anthracene by two exposure routes at different developmental stages. Toxicol Pathol 2000, 28:705-715.
36. Spitsbergen J.M., Tsai H.W., Reddy A., Miller T, Arbogast D, Hendricks JD, et al. Neoplasia in zebrafish (Danio rerio) treated with N-methyl-N'-nitro-N-nitrosoguanidine by three exposure routes at different developmental stages. Toxicol Pathol 2000, 28:716-725.
37. Stern H.M., Zon L.I. Cancer genetics and drug discovery in the zebrafish. Nat Rev Cancer 2003, 3:533-539.
38. Mullins M.C., Hammerschmidt M., Haffter P., Nusslein-Volhard C. Large-scale mutagenesis in the zebrafish: in search of genes controlling development in a vertebrate. Curr Biol 1994, 4:189-202.
39. Zon L.I., Peterson R.T. In vivo drug discovery in the zebrafish. Nat Rev Drug Discov 2005, 4:35-44.
40. Amsterdam A., Hopkins N. Mutagenesis strategies in zebrafish for identifying genes involved in development and disease. Trends Genet 2006, 22:473-478.
41. Soucy T.A., Smith P.G., Milhollen M.A., Berger AJ, Gavin JM, Adhikari S, et al. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature 2009, 458:732-736.
42. Langenau D.M., Traver D., Ferrando A.A., Kutok JL, Aster JC, Kanki JP, et al. Myc-induced T cell leukemia in transgenic zebrafish. Science 2003, 299:887-890.
43. Wu M., Jung L., Cooper A.B., Fleet C, Chen L, Breault L, et al. Dissecting genetic requirements of human breast tumorigenesis in a tissue transgenic model of human breast cancer in mice. Proc Natl Acad Sci USA 2009, 106:7022-7027.
44. Konantz M., Balci T.B., Hartwig U.F., Dellaire G, Andre MC, Berman JN, et al. Zebrafish xenografts as a tool for in vivo studies on human cancer. Ann NY Acad Sci 2012, 1266:124-137.
45. Moore F.E., Langenau D.M. Through the looking glass: visualizing leukemia growth, migration, and engraftment using fluorescent transgenic zebrafish. Adv Hematol 2012, 2012:478164.
46. Berman J., Hsu K., Look A.T. Zebrafish as a model organism for blood diseases. Br J Haematol 2003, 123:568-576.
47. Langenau D.M., Feng H., Berghmans S., Kanki J.P., Kutok J.L., Look A.T. Cre/lox-regulated transgenic zebrafish model with conditional myc-induced T cell acute lymphoblastic leukemia. Proc Natl Acad Sci USA 2005, 102:6068-6073.
48. Forrester A.M., Grabher C., McBride E.R., Boyd ER, Vigerstad MH, Edgar A, et al. NUP98-HOXA9-transgenic zebrafish develop a myeloproliferative neoplasm and provide new insight into mechanisms of myeloid leukaemogenesis. Br J Haematol 2011, 155:167-181.
49. Campbell L.J., Willoughby J.J., Jensen A.M. Two types of tet-on transgenic lines for doxycycline-inducible gene expression in zebrafish rod photoreceptors and a gateway-based tet-on toolkit. PLoS One 2012, 7:e51270.
50. Li Z., Huang X., Zhan H., Zeng Z, Li C, Spitsbergen JM, et al. Inducible and repressable oncogene-addicted hepatocellular carcinoma in Tet-on xmrk transgenic zebrafish. J Hepatol 2012, 56:419-425.
51. Li Z., Zheng W., Wang Z., Zeng Z, Zhan H, Li C, et al. A transgenic zebrafish liver tumor model with inducible Myc expression reveals conserved Myc signatures with mammalian liver tumors. Dis Model Mech 2012, 6(2):414-423.
52. Foley J.E., Maeder M.L., Pearlberg J., Joung J.K., Peterson R.T., Yeh J.R. Targeted mutagenesis in zebrafish using customized zinc-finger nucleases. Nat Protoc 2009, 4:1855-1867.
53. Foley J.E., Yeh J.R., Maeder M.L., Reyon D, Sander JD, Peterson RT, et al. Rapid mutation of endogenous zebrafish genes using zinc finger nucleases made by Oligomerized Pool ENgineering (OPEN). PLoS One 2009, 4:e4348.
54. Cade L., Reyon D., Hwang W.Y., Tsai SQ, Patel S, Khayter C, et al. Highly efficient generation of heritable zebrafish gene mutations using homo- and heterodimeric TALENs. Nucleic Acids Res 2012, 40:8001-8010.
55. Moore F.E., Reyon D., Sander J.D., Martinez SA, Blackburn JS, Khayter C, et al. Improved somatic mutagenesis in zebrafish using transcription activator-like effector nucleases (TALENs). PLoS One 2012, 7:e37877.
56. Sander J.D., Cade L., Khayter C., Reyon D, Peterson RT, Joung JK, et al. Targeted gene disruption in somatic zebrafish cells using engineered TALENs. Nat Biotechnol 2011, 29:697-698.
57. Detrich H.W., Westerfield M., Zon L.I. Overview of the zebrafish system. Methods Cell Biol 1999, 59:3-10.
58. Rowell J.L., McCarthy D.O., Alvarez C.E. Dog models of naturally occurring cancer. Trends Mol Med 2011, 17:380-388.
59. Paoloni M., Khanna C. Translation of new cancer treatments from pet dogs to humans. Nat Rev Cancer 2008, 8:147-156.
60. Vail D.M., MacEwen E.G. Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Invest 2000, 18:781-792.
61. Jonasdottir T.J., Mellersh C.S., Moe L., Heggebo R, Gamlem H, Ostrander EA, et al. Genetic mapping of a naturally occurring hereditary renal cancer syndrome in dogs. Proc Natl Acad Sci USA 2000, 97:4132-4137.
62. Lingaas F., Comstock K.E., Kirkness E.F., Sorensen A, Aarskaug T, Hitte C, et al. A mutation in the canine BHD gene is associated with hereditary multifocal renal cystadenocarcinoma and nodular dermatofibrosis in the German Shepherd dog. Hum Mol Genet 2003, 12:3043-3053.
63. Rosenberger J.A., Pablo N.V., Crawford P.C. Prevalence of and intrinsic risk factors for appendicular osteosarcoma in dogs: 179 cases (1996-2005). J Am Vet Med Assoc 2007, 231:1076-1080.
64. Rous P. A sarcoma of the fowl transmissible by an agent separable from the tumor cells. J Exp Med 1911, 13:397-399.
65. Rubin H. The early history of tumor virology: Rous, RIF, and RAV. Proc Natl Acad Sci USA 2011, 108:14389-14396.
66. Plachy J., Hejnar J. Chicken cells - oncogene transformation, immortalization and more. Folia Biol (Praha) 2002, 48:126-138.
67. Purchase H.G. Prevention of Marek's disease: a review. Cancer Res 1976, 36:696-700.
68. Ross N.L. T-cell transformation by Marek's disease virus. Trends Microbiol 1999, 7:22-29.
69. Shibata H., Toyama K., Shioya H., Ito M, Hirota M, Hasegawa S, et al. Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science 1997, 278:120-123.
70. Yamazoe M., Sonoda E., Hochegger H., Takeda S. Reverse genetic studies of the DNA damage response in the chicken B lymphocyte line DT40. DNA Repair (Amst) 2004, 3:1175-1185.
71. Barua A., Bitterman P., Abramowicz J.S., Dirks AL, Bahr JM, Hales DB, et al. Histopathology of ovarian tumors in laying hens: a preclinical model of human ovarian cancer. Int J Gynecol Cancer 2009, 19:531-539.
72. Lim W., Kim H.S., Jeong W., Ahn SE, Kim J, Kim YB, et al. SERPINB3 in the chicken model of ovarian cancer: a prognostic factor for platinum resistance and survival in patients with epithelial ovarian cancer. PLoS One 2012, 7:e49869.
73. Tufan A.C., Satiroglu-Tufan N.L. The chick embryo chorioallantoic membrane as a model system for the study of tumor angiogenesis, invasion and development of anti-angiogenic agents. Curr Cancer Drug Targets 2005, 5:249-266.
74. International Chicken Genome Sequencing Consortium. Sequence and comparative analysis of the chicken genome provide unique perspectives on vertebrate evolution. Nature 2004;432:695-716.
75. Polesello C., Roch F., Gobert V., Haenlin M., Waltzer L. Modeling cancers in Drosophila. Prog Mol Biol Transl Sci 2011, 100:51-82.
76. Zhivotovsky B., Orrenius S. Carcinogenesis and apoptosis: paradigms and paradoxes. Carcinogenesis 2006, 27:1939-1945.
77. Zamore P.D. RNA interference: big applause for silencing in Stockholm. Cell 2006, 127:1083-1086.
78. Mohr S.E., Perrimon N. RNAi screening: new approaches, understandings, and organisms. Wiley Interdiscip Rev RNA 2011, 3:145-158.
79. Stark M.B. An hereditary tumor in Drosophila. J Cancer Res 1918, 3:279-301.
80. Potter C.J., Turenchalk G.S., Xu T. Drosophila in cancer research. An expanding role. Trends Genet 2000, 16:33-39.
81. Ranganathan P., Weaver K.L., Capobianco A.J. Notch signalling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer 2011, 11:338-351.
82. Sternberg P.W., Han M. Genetics of RAS signaling in C. elegans. Trends Genet 1998, 14:466-472.
83. Chen K., Ahmed S., Adeyi O., Dick J., Ghanekar A. Human solid tumor xenografts in immunodeficient mice are vulnerable to lymphomagenesis associated with Epstein-Barr virus. PLoS One 2012, 7:e39294.
84. Gladstone M., Su T.T. Chemical genetics and drug screening in Drosophila cancer models. J Genet Genomics 2011, 38:497-504.
85. Gonsalves F.C., Klein K., Carson B.B., Katz S, Ekas LA, Evans S, et al. An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway. Proc Natl Acad Sci USA 2011, 108:5954-5963.
86. Donehower L.A., Harvey M., Slagle B.L., McArthur MJ, Montgomery CA, Butel JS, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992, 356:215-221.
87. Stewart T.A., Pattengale P.K., Leder P Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 1984, 38:627-637.
88. Allen J.M., Forbush K.A., Perlmutter RM Functional dissection of the lack proximal promoter. Mol Cell Biol 1992, 12:2758-2768.
89. Wildin R.S., Wang H.U., Forbrush KA, Perlmutter RM Functional dissection of the murine lck distal promoter. J Immunol 1995, 155:1286-1295.
90. Kasper S. Survey of genetically engineered mouse models for prostate cancer: analyzing the molecular basis of prostate cancer development, progression, and metastasis. J Cell Biochem 2005, 94:279-297.
91. Zhang J., Gao N., DeGraff DJ, Yu X, Sun Q, Case TC, et al. Characterization of cis elements of the probasin promoter necessary for prostate-specific gene expression. Prostate 2010, 70:934-951.
92. Chiu I., Touhalisky K., Liu Y, Yates A, Frostholm A Tumorigenesis in transgenic mice in which the SV40 T antigen is driven by the brain-specific FGF1 promoter. Oncogene 2000, 19:6229-6239.
93. Qian F., Hanahan D., Weissman IL L-selectin can facilitate metastasis to lymph nodes in a transgenic mouse model of carcinogenesis. Proc Natl Acad Sci USA 2001, 98:3976-3981.
94. Adams J.M., Cory S. Transgenic models of tumor development. Science 1991, 254:1161-1167.
95. Ewald D., Li M., Efrat S., Auer G, Wall RJ, Furth PA, et al. Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Science 1996, 273:1384-1386.
96. Landesman-Bollag E., Channavajhala P., Cardiff R., Seldin D. p53 deficiency and misexpression of protein kinase CK2alpha collaborate in the development of thymic lymphomas in mice. Oncogene 1998, 16:2965-2974.
97. McCormack S., Weaver Z., Deming S., Natarajan N., Torri J., Johnson MD., et al. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability. Oncogene 1998, 16:2755-2766.
98. Sauer B., Henderson N. Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc Natl Acad Sci USA 1988, 85:5166-5170.
99. Meuwissen R., Linn S., van der Valk M., Mooi W., Berns A. Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene. Oncogene 2001, 20:6551-6558.
100. Gu H., Marth J., Orban P., Mossmann H., Rajewsky K. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 1994, 265:103-106.
101. McLeod M., Craft S., Broach J.R. Identification of the crossover site during FLP-mediated recombination in the Saccaromyces cerevisiae plasmid 2μm circle. Mol Cell Biol 1986, 6:3357-3367.
102. Tuveson D., Shaw A., Willis N., Silver DP., Jackson EL., Chang S., et al. Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell 2004, 5:375-387.
103. Marino S., Vooijs M., van der Gulden H., Jonkers J., Berns A. Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes Dev 2000, 14:994-1004.
104. Trimboli A., Cantemir-Stone C., Li F., Wallace JA., Merchant A., Creasap N., et al. Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature 2009, 461:1084-1091.
105. Zhou Y., Rideout W.R., Zi T., Bressel A., Reddypalli S., Rancourt R., et al. Chimeric mouse tumor models reveal differences in pathway activation between ERBB family- and KRAS-dependent lung adenocarcinomas. Nat Biotechnol 2010, 28:71-78.
106. Pear W.S., Miller J.P., Xu L., Pui JC., Soffer B., Quackenbush RC., et al. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood 1998, 92:3780-3792.
107. Zender L., Spector M., Xue W., Flemming P., Cordon-Cardo C., Silke J., et al. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 2006, 125:1253-1267.
108. Bhowmick N.A., Neilson E.G., Moses H.L. Stromal fibroblasts in cancer initiation and progression. Nature 2004, 432:332-337.
109. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
110. Huber S., Gagliani N., Zenewicz L.A., Huber FJ., Bosurgi L., Hu B., et al. IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature 2012, 491:259-263.
111. Qian F., Hanahan D., Weissman I. L-selectin can facilitate metastasis to lymph nodes in a transgenic mouse model of carcinogenesis. Proc Natl Acad Sci USA 2001, 98:3976-3981.
112. Hill R., Song Y., Cardiff R., van Dyke T. Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis. Cell 2005, 123:1001-1011.
113. Nunez-Cruz S., Gimotty P.A., Guerra M.W., Connolly DC., Wu YQ., DeAngelis RA., et al. Genetic and pharmacologic inhibition of complement impairs endothelial cell function and ablates ovarian cancer neovascularization. Neoplasia 2012, 14:994-1004.
114. Amacher S.L. Transcriptional regulation during zebrafish embryogenesis. Curr Opin Genet Dev 1999, 9:548-552.
115. Jessen J.R., Willett C.E., Lin S. Artificial chromosome transgenesis reveals long-distance negative regulation of rag1 in zebrafish. Nat Genet 1999, 23:15-16.
116. Carradice D., Lieschke G.J. Zebrafish in hematology: sushi or science?. Blood 2008, 111:3331-3342.
117. Yeh J.R., Munson K.M., Chao Y.L., Peterson Q.P., Macrae C.A., Peterson R.T. AML1-ETO reprograms hematopoietic cell fate by downregulating scl expression. Development 2008, 135:401-410.
118. Le X., Langenau D.M., Keefe M.D., Kutok J.L., Neuberg D.S., Zon L.I. Heat shock-inducible Cre/Lox approaches to induce diverse types of tumors and hyperplasia in transgenic zebrafish. Proc Natl Acad Sci USA 2007, 104:9410-9415.
119. Sabaawy H.E., Azuma M., Embree L.J., Tsai H.J., Starost M.F., Hickstein D.D. TEL-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia. Proc Natl Acad Sci USA 2006, 103:15166-15171.
120. Dovey M., White R.M., Zon L.I. Oncogenic NRAS cooperates with p53 loss to generate melanoma in zebrafish. Zebrafish 2009, 6:397-404.
121. Leacock S.W., Basse A.N., Chandler G.L., Kirk A.M., Rakheja D., Amatruda J.F. A zebrafish transgenic model of Ewing's sarcoma reveals conserved mediators of EWS-FLI1 tumorigenesis. Dis Model Mech 2012, 5:95-106.
122. Patton E.E., Widlund H.R., Kutok J.L., Kopani KR., Amatruda JF., Murphey RD., et al. BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma. Curr Biol 2005, 15:249-254.
123. Park S.W., Davison J.M., Rhee J., Hruban R.H., Maitra A., Leach S.D. Oncogenic KRAS induces progenitor cell expansion and malignant transformation in zebrafish exocrine pancreas. Gastroenterology 2008, 134:2080-2090.
124. Thermes V., Grabher C., Ristoratore F., Bourrat F., Choulika A., Wittbrodt J., et al. I-SceI meganuclease mediates highly efficient transgenesis in fish. Mech Dev 2002, 118:91-98.
125. Kawakami K. Transposon tools and methods in zebrafish. Dev Dyn 2005, 234:244-254.
126. Villefranc J.A., Amigo J., Lawson N.D. Gateway compatible vectors for analysis of gene function in the zebrafish. Dev Dyn 2007, 236:3077-3087.
127. + tumor-initiating cell population with an aggressive signature and metastatic capacity in esophageal cancer. Cancer Res 2013, 73(7):2322-2332.
128. Langenau D.M., Keefe M.D., Storer N.Y., Jette CA., Smith ACH., Ceol CJ., et al. Co-injection strategies to modify radiation sensitivity and tumor initiation in transgenic zebrafish. Oncogene 2008, 27:4242-4248.
129. Blackburn C., Augustine C., Li R., Harvey RP., Malin MA., Boyd RL., et al. The nu gene acts cell-autonomously and is required for differentiation of thymic epithelial progenitors. Proc Natl Acad Sci USA 1996, 93:5742-5746.
130. Povlsen C., Fialkow P., Klein E., Klein G., Rygaard J., Wiener F. Growth and antigenic properties of a biopsy-derived Burkitt's lymphoma in thymus-less (nude) mice. Int J Cancer 1973, 11:30-39.
131. Rygaard J., Povlsen C. Heterotransplantation of a human malignant tumour to "Nude" mice. Acta Pathol Microbiol Scand 1969, 77:758-760.
132. Povlsen C., Rygaard J. Heterotransplantation of human epidermoid carcinomas to the mouse mutant nude. Acta Pathol Microbiol Scand A 1972, 80:713-717.
133. Giovanella B., Yim S., Stehlin J., Williams L.J. Development of invasive tumors in the "nude" mouse after injection of cultured human melanoma cells. J Natl Cancer Inst 1972, 48:1531-1533.
134. Fulop G., Phillips R.A. The scid mutation in mice causes a general defect in DNA repair. Nature 1990, 347:479-482.
135. De Lord C., Clutterbuck R., Titley J., Ormerod M., Gordon-Smith T., Millar J., et al. Growth of primary human acute leukemia in severe combined immunodeficient mice. Exp Hematol 1991, 19:991-993.
136. Fu X., Hoffman R. Human ovarian carcinoma metastatic models constructed in nude mice by orthotopic transplantation of histologically-intact patient specimens. Anticancer Res 1993, 13:283-286.
137. Williams K., Ghosh R., Giridhar P., Gu G., Case T., Belcher SM., et al. Inhibition of stathmin1 accelerates the metastatic process. Cancer Res 2012, 72:5407-5417.
138. Juhasz I., Albelda S., Elder D., Murphy GF., Adachi K., Herlyn D., et al. Growth and invasion of human melanomas in human skin grafted to immunodeficient mice. Am J Pathol 1993, 143:528-537.
139. Takahashi H., Nakada T., Puisieux I. Inhibition of human colon cancer growth by antibody-directed human LAK cells in SCID mice. Science 1993, 259(5100):1460-1463.
140. Pflumio F., Fonteneau P., Gavériaux C., Cammisuli S., Loor F. The C57BL/6 nude, beige mouse: a model of combined T cell and NK effector cell immunodeficiency. Cell Immunol 1989, 120:218-229.
141. Amsbaugh D.F., Hansen C.T., Prescott B., Stashak P.W., Barthold D.R., Baker P.J. Genetic control of the antibody response to type III pneumococcal polysaccharide in mice: I. Evidence that an X-linked gene plays a decisive role in determining responsiveness. J Exp Med 1972, 136:931-949.
142. Kamel-Reid S., Dick J. Engraftment of immune-deficient mice with human hematopoietic stem cells. Science 1988, 242:1706-1709.
143. Mulé J., Jicha D., Aebersold P., Travis W., Rosenberg S. Disseminated human malignant melanoma in congenitally immune-deficient (bg/nu/xid) mice. J Natl Cancer Inst 1991, 83:350-355.
144. Nonoyama S., Smith F.O., Bernstein I.D., Ochs H.D. Strain-dependent leakiness of mice with severe combined immune deficiency. J Immunol 1993, 150:3817-3824.
145. Shultz L.D., Schweitzer P.A., Christianson S.W., Gott B., Schweitzer IB., Tennent B., et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 1995, 154:180-191.
146. Tanaka T., Kitamura F., Nagasaka Y., Kuida K., Suwa H., Miyasaka M. Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor β chain monoclonal antibody in mice. J Exp Med 1993, 178:1103-1107.
147. Notta F., Mullighan C.G., Wang J.C.Y., Poeppl A., Doulatov S., Phillips LA., et al. Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells. Nature 2011, 471:254.
148. Masramon L., Vendrell E., Tarafa G., Capella G., Miro R., Ribas M., et al. Genetic instability and divergence of clonal populations in colon cancer cells in vitro. J Cell Sci 2006, 119:1477-1482.
149. Oettinger M., Schatz D.G., Gorka C., Baltimore D. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 1990, 248:1517-1523.
150. Shultz L., Lang P., Christianson S., Gott B., Lyons B., Umeda S., et al. NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells. J Immunol 2000, 164:2496-2507.
151. Söderstrøm I., Bergman M., Colucci F., Lejon K., Bergqvist I., Holmberg D. Establishment and characterization of RAG-2 deficient non-obese diabetic mice. Scand J Immunol 1996, 43:525-530.
152. null mice. Blood 2005, 106:1565-1573.
153. null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 2005, 174:6477-6489.
154. Francia G., Cruz-Munoz W., Man S., Xu P., Kerbel R.S. Mouse models of advanced spontaneous metastasis for experimental therapeutics. Nat Rev Cancer 2011, 11:135-144.
155. Pearson T., Greiner D., Shultz L. Humanized SCID mouse models for biomedical research. Curr Top Microbiol Immunol 2008, 324:25-51.
156. Bonnet D., Dick J. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997, 3:730-737.
157. Eramo A., Lotti F., Sette G., Pilozzi E., Biffoni M., Di Virgilio A., et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 2008, 15:504-514.
158. + cancer stem cells in human liver cancer. Cancer Cell 2008, 13:153-166.
159. Eppert K., Takenaka K., Lechman E., Waldron L., Nilsson B., van Galen P., et al. Stem cell gene expression programs influence clinical outcome in human leukemia. Nat Med 2011, 17:1086-1093.
160. Wang J., Dick J. Cancer stem cells: lessons from leukemia. Trends Cell Biol 2005, 15:494-501.
161. Quintana E., Piskounova E., Shackleton M., Weinberg D., Eskiocak U., Fullen DR., et al. Human melanoma metastasis in NSG mice correlates with clinical outcome in patients. Science Translat Med 2012, 4:149-159.
162. Eaves C.J. Cancer stem cells: here, there, everywhere?. Nature 2008, 456:581-582.
163. Ossowski L., Reich E. Experimental model for quantitative study of metastasis. Cancer Res 1980, 40:2300-2309.
164. Scher C., Haudenschild C., Klagsbrun M. The chick chorioallantoic membrane as a model system for the study of tissue invasion by viral transformed cells. Cell 1976, 8:373-382.
165. Lee L.M., Seftor E.A., Bonde G., Cornell R.A., Hendrix M.J. The fate of human malignant melanoma cells transplanted into zebrafish embryos: assessment of migration and cell division in the absence of tumor formation. Dev Dyn 2005, 233:1560-1570.
166. Corkery D.P., Dellaire G., Berman J.N. Leukaemia xenotransplantation in zebrafish - chemotherapy response assay in vivo. Br J Haematol 2011, 153:786-789.
167. Veinotte CJ, Corkery D, Dellaire G, El-Naggar A, Sinclair K, Bernstein ML, et al. Using zebrafish xenotransplantation to study the role of Y-Box binding protein (YB-1) in the metastasis of Ewing family tumors. American Academy of Cancer Research Annual Meeting, Abstract 1398; 2012.
168. Pruvot B, Jacquel A, Droin N, et al. 2011 Leukemia cell xenograft in zebrafish embryo for investigating drug efficacy. Haematologica 2011;96(4):612-6.
169. Stoletov K., Kato H., Zardouzian E., Kelber J., Yang J., Shattil S., et al. Visualizing extravasation dynamics of metastatic tumor cells. J Cell Sci 2010, 123:2332-2341.
170. Lam S.H., Chua H.L., Gong Z., Lam T.J., Sin Y.M. Development and maturation of the immune system in zebrafish, Danio rerio: a gene expression profiling, in situ hybridization and immunological study. Dev Comp Immunol 2004, 28:9-28.
171. Haldi M., Ton C., Seng W.L., McGrath P. Human melanoma cells transplanted into zebrafish proliferate, migrate, produce melanin, form masses and stimulate angiogenesis in zebrafish. Angiogenesis 2006, 9:139-151.
172. Nicoli S., Ribatti D., Cotelli F., Presta M. Mammalian tumor xenografts induce neovascularization in zebrafish embryos. Cancer Res 2007, 67:2927-2931.
173. Detrich H.W., Westerfield M., Zon L.I. The zebrafish: cellular and developmental biology, part A. Preface. Methods Cell Biol 2010, 100. xiii.
174. Geiger G.A., Fu W., Kao G.D. Temozolomide-mediated radiosensitization of human glioma cells in a zebrafish embryonic system. Cancer Res 2008, 68:3396-3404.
175. Marques I.J., Weiss F.U., Vlecken D.H., Nitsche C., Bakkers J., Lagendijk AK., et al. Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model. BMC Cancer 2009, 9:128.
176. Stoletov K., Montel V., Lester R.D., Gonias S.L., Klemke R. High-resolution imaging of the dynamic tumor cell vascular interface in transparent zebrafish. Proc Natl Acad Sci USA 2007, 104:17406-17411.
177. Huynh A.S., Abrahams D.F., Torres M.S., Baldwin M.K., Gillies R.J., Morse D.L. Development of an orthotopic human pancreatic cancer xenograft model using ultrasound guided injection of cells. PLoS One 2011, 6:e20330.
178. Traver D., Paw B.H., Poss K.D., Penberthy W.T., Lin S., Zon L.I. Transplantation and in vivo imaging of multilineage engraftment in zebrafish bloodless mutants. Nat Immunol 2003, 4:1238-1246.
179. Berman J, Hsu K, Liu TX, et al. A transgenic zebrafish model of Hoxa9 and Meis1 mediated myeloid leukemias. 6th International Conference on Zebrafish Development and Genetics; 2004.
180. Smith A.C., Raimondi A.R., Salthouse C.D., Ignatius MS., Blackburn JS., Mizgirev IV., et al. High-throughput cell transplantation establishes that tumor-initiating cells are abundant in zebrafish T-cell acute lymphoblastic leukemia. Blood 2010, 115:3296-3303.
181. Eguiara A., Holgado O., Beloqui I., Abalde L., Sanchez Y., Callol C., et al. Xenografts in zebrafish embryos as a rapid functional assay for breast cancer stem-like cell identification. Cell Cycle 2011, 10:3751-3757.
182. Lichtenstein A.V. Cancer: evolutionary, genetic and epigenetic aspects. Clin Epigenet 2010, 1:85-100.
183. Corkery D, Balci TB, Berman JN, Dellaire G. Evaluating novel targeted therapeutic agents in T-cell acute lymphoblastic leukemia using a zebrafish xenotransplantation model. American Academy of Cancer Research Annual Meeting, Abstract 4251; 2012.
184. Ma D, Ramachandran A, Chang Y, Lin J, Zhang W, Tai YT, et al. Differences in the angiogenic response and subsequent growth of plasma cells from myeloma and MGUS patients xenografted into zebrafish embryos. Blood (ASH Annual Meeting Abstracts) 2012;120(21):2912.
185. Wang J.C., Lapidot T., Cashman J.D., Doedens M., Addy L., Sutherland DR., et al. High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase. Blood 1998, 91:2406-2414.
186. Walter M.J., Shen D., Ding L., Shao J., Koboldt DC., Chen K., et al. Clonal architecture of secondary acute myeloid leukemia. N Engl J Med 2012, 366:1090-1098.
187. Ding L., Ley T.J., Larson D.E., Miller CA., Koboldt DC., Welch JS., et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 2011, 481:506-510.
188. Schmitz M., Breithaupt P., Scheidegger N., Cario G., Bonapace L., Meissner B., et al. Xenografts of highly resistant leukemia recapitulate the clonal composition of the leukemogenic compartment. Blood 2011, 118:1854-1864.
189. Harismendy O., Schwab R., Bao L., Olson J., Rozenzhak S., Kotsopoulos SK., et al. Detection of low prevalence somatic mutations in solid tumors with ultra-deep targeted sequencing. Genome Biol 2011, 12:R124.
190. Lawson N.D., Weinstein B.M. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol 2002, 248:307-318.
191. Renshaw S.A., Loynes C.A., Trushell D.M., Elworthy S., Ingham P.W., Whyte M.K. A transgenic zebrafish model of neutrophilic inflammation. Blood 2006, 108:3976-3978.
192. He S., Lamers G.E., Beenakker J.W., Cui C., Ghotra VP., Danen EH., et al. Neutrophil-mediated experimental metastasis is enhanced by VEGFR inhibition in a zebrafish xenograft model. J Pathol 2012, 227:431-445.
193. Ellett F., Pase L., Hayman J.W., Andrianopoulos A., Lieschke G.J. mpeg1 promoter transgenes direct macrophage-lineage expression in zebrafish. Blood 2011, 117:e49-e56.
194. Lin H.F., Traver D., Zhu H., Dooley K., Paw BH., Zon LI., et al. Analysis of thrombocyte development in CD41-GFP transgenic zebrafish. Blood 2005, 106:3803-3810.
195. Ma D., Zhang J., Lin H.F., Italiano J., Handin R.I. The identification and characterization of zebrafish hematopoietic stem cells. Blood 2011, 118:289-297.
196. White R.M., Sessa A., Burke C., Bowman T., LeBlanc J., Ceol C., et al. Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell 2008, 2:183-189.
197. Sharpless N.E. INK4a/ARF: a multifunctional tumor suppressor locus. Mutat Res 2005, 576:22-38.